Virus-like particle vaccines

Virus-like particle vaccines

Vaccines are among the most successful and cost-effective public health tools for preventing infectious diseases and death. Virus-like particles (VLPs) have made impressive progress in the field of vaccinology over the last three decades so that several VLP-based vaccines are commercially available...

Bibliografske podrobnosti
Main Authors:	Mukhopadhyay, E, Hill, AVS, Salman, AM
Drugi avtorji:	Ashfield, R
Format:	Book section
Jezik:	English
Izdano:	Academic Press 2022

Podobne knjige/članki

Virus-like particles as vaccine adjuvants.
od: Gilbert, S
Izdano: (2001)

Virus-like Particle Vaccines and Platforms for Vaccine Development
od: Milad Kheirvari, et al.
Izdano: (2023-05-01)

Preclinical Development of a Novel Zika Virus-like Particle Vaccine in Combination with Tetravalent Dengue Virus-like Particle Vaccines
od: Dominik A. Rothen, et al.
Izdano: (2024-09-01)

The coming of age of virus-like particle vaccines.
od: Jennings, G, et al.
Izdano: (2008)

Special Issue “Virus-Like Particle Vaccines”
od: Monique Vogel, et al.
Izdano: (2020-08-01)

Ty virus-like particles, DNA vaccines and Modified Vaccinia Virus Ankara; comparisons and combinations.
od: Gilbert, S, et al.
Izdano: (1999)

Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine
od: Gilbert, S, et al.
Izdano: (2017)

Virus-Like Particles as an Immunogenic Platform for Cancer Vaccines
od: Jerri C. Caldeira, et al.
Izdano: (2020-04-01)

Virus-like Particles as Preventive and Therapeutic Cancer Vaccines
od: Anna Lucia Tornesello, et al.
Izdano: (2022-02-01)

Zika virus-like particle (VLP) based vaccine.
od: Hélène Boigard, et al.
Izdano: (2017-05-01)

Characterization of Zika virus-like particles as potential vaccine antigens
od: G. Brzuska, et al.
Izdano: (2020-12-01)

Versatile virus-like particle carrier for epitope based vaccines
od: Tissot, A, et al.
Izdano: (2010)

The 5th virus-like particle and nano-particle vaccines (VLPNPV) conference
od: Paul Engeroff, et al.
Izdano: (2019-01-01)

Virus like particles as a platform for cancer vaccine development
od: Hui, Kian Ong, et al.
Izdano: (2017)

Virus-like particles as a modular system for novel vaccines.
od: Lechner, F, et al.
Izdano: (2002)

Escherichia coli-derived virus-like particles in vaccine development
od: Xiaofen Huang, et al.
Izdano: (2017-02-01)

Virus like particles as a platform for cancer vaccine development
od: Hui Kian Ong, et al.
Izdano: (2017-11-01)

Identification of Novel Adjuvants for Ebola Virus-Like Particle Vaccine
od: Huapeng Feng, et al.
Izdano: (2020-05-01)

Virus-like particle vaccines: immunology and formulation for clinical translation
od: Braeden Donaldson, et al.
Izdano: (2018-09-01)

Next generation designer virus-like particle vaccines for dengue
od: Rahul Shukla, et al.
Izdano: (2019-02-01)

Enveloped virus-like particles as a platform for vaccine development
od: Francisco Diaz-Mitoma
Izdano: (2021-01-01)

Progress in the Production of Virus-Like Particles for Vaccination against Hepatitis E Virus
od: Milena Mazalovska, et al.
Izdano: (2020-07-01)

Virus-Like Particle Systems for Vaccine Development against Viruses in the Flaviviridae Family
od: Shu Hui Wong, et al.
Izdano: (2019-09-01)

Virus-like Particles (VLPs) as Important Tools for Flavivirus Vaccine Development
od: Leda R. Castilho, et al.
Izdano: (2022-10-01)

Virus-Like Particle, Liposome, and Polymeric Particle-Based Vaccines against HIV-1
od: Yong Gao, et al.
Izdano: (2018-02-01)

Vaccination with a chikungunya virus-like particle vaccine exacerbates disease in aged mice.
od: Maria T Arévalo, et al.
Izdano: (2019-04-01)

Bacterially produced recombinant influenza vaccines based on virus-like particles
od: Jegerlehner, A, et al.
Izdano: (2013)

Virus-like particles in poultry disease: an approach to effective and safe vaccination
od: Abdullahi Abdullahi Raji, et al.
Izdano: (2024-09-01)

Recent Advances in the Development of Virus-Like Particle-Based Flavivirus Vaccines
od: Naru Zhang, et al.
Izdano: (2020-08-01)

Nanometric Virus-Like Particles: Key Tools for Vaccine and Adjuvant Technology
od: Giuseppe Bardi
Izdano: (2020-07-01)

Development of virus-like particles with inbuilt immunostimulatory properties as vaccine candidates
od: Simon Collett, et al.
Izdano: (2023-06-01)

Platforms, advances, and technical challenges in virus-like particles-based vaccines
od: Reeshu Gupta, et al.
Izdano: (2023-02-01)

The Rationale for a Preventative HCV Virus-Like Particle (VLP) Vaccine
od: Joseph Torresi
Izdano: (2017-11-01)

Bacterially produced recombinant influenza vaccines based on virus-like particles.
od: Andrea Jegerlehner, et al.
Izdano: (2013-01-01)

Design Concepts of Virus-Like Particle-Based HIV-1 Vaccines
od: Chun-Wei Chen, et al.
Izdano: (2020-09-01)

Efficient expression of enterovirus 71 based on virus-like particles vaccine.
od: Hye-Jin Kim, et al.
Izdano: (2019-01-01)

Effective chikungunya virus-like particle vaccine produced in insect cells.
od: Stefan W Metz, et al.
Izdano: (2013-01-01)

Virus-Like Particles (VLPs) platform for the development of an effective melanoma vaccine
od: Mohsen, M
Izdano: (2018)

Multifaceted virus-like particles: Navigating towards broadly effective influenza A virus vaccines
od: Jaffar Ali Muhamad Norizwan, et al.
Izdano: (2025-01-01)

Pigs Immunized with the Virus-like Particle Vaccine Are Protected against the Hepatitis E-3 Virus
od: Hyeon-Jeong Go, et al.
Izdano: (2021-11-01)